RSS   Newsletter   Contact   Advertise with us
Post Online Media

Aimmune Therapeutics appoints Eric Bjerkholt as CFO

Eric BjerkholtAimmune Therapeutics, a clinical-stage biopharmaceutical company, announced the appointment of Eric Bjerkholt as chief financial officer.
Article continues below

READ MORE Aimmune Therapeutics COO Howard Raff to retire

Mr. Bjerkholt joins Aimmune from Sunesis Pharmaceuticals, Inc., where, over 13 years with the company, his role as CFO expanded to oversee multiple aspects of governance, corporate relations, and other functions.

Prior to Sunesis, Mr. Bjerkholt was CFO at IntraBiotics Pharmaceuticals, Inc., and LifeSpring Nutrition, Inc.

He began his healthcare career at J.P. Morgan & Co. as an investment banker in New York and then launched the company’s Western U.S. healthcare practice.

Mr. Bjerkholt holds a Cand. Oecon. (master’s) degree in economics from the University of Oslo and an M.B.A. from Harvard Business School.

He has served on the boards of directors of several publicly traded companies and is currently a member of the board of directors and chair of the audit committee for Corium International, Inc.



We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy